Literature DB >> 26741655

Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice.

Kyung Eun Kim1, Keon-Hee Ko2,3, Rok Won Heo1, Chin-ok Yi1, Hyun Joo Shin1, Jun Young Kim4, Jae-Ho Park5, Sanghae Nam3, Hwajin Kim1, Gu Seob Roh1.   

Abstract

Artemisia annua L. (AA) is a well-known source of the antimalarial drug artemisinin. AA also has an antibacterial and antioxidant activity. However, the effect of AA extract on hepatic steatosis induced by obesity is unclear. We investigated whether AA extract prevents obesity-induced insulin resistance and hepatic steatosis in high-fat diet (HFD)-fed mice. Mice were randomly divided into groups that received a normal chow diet or HFD with or without AA for 12 weeks. We found that AA extract reduced insulin resistance and hepatic steatosis in HFD-fed mice. Western blot analysis showed that HFD-induced expression of nuclear sterol regulatory element-binding protein 1 and carbohydrate-responsive element-binding protein in the livers was decreased by AA extract. In particular, dietary administration of AA extract decreased hepatic high-mobility group box 1 and cyclooxygenase-2 expression in HFD-fed mice. AA extract also attenuated HFD-induced collagen deposition and fibrosis-related transforming growth factor-β1 and connective tissue growth factor. These data indicate that dietary AA extract has beneficial effects on hepatic steatosis and inflammation in HFD-fed mice.

Entities:  

Keywords:  Artemisia annua L.; hepatic inflammation; hepatic steatosis; obesity

Mesh:

Substances:

Year:  2016        PMID: 26741655      PMCID: PMC4799707          DOI: 10.1089/jmf.2015.3527

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  34 in total

1.  alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity.

Authors:  T Matsui; T Ueda; T Oki; K Sugita; N Terahara; K Matsumoto
Journal:  J Agric Food Chem       Date:  2001-04       Impact factor: 5.279

2.  Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.

Authors:  Jing Chen; Diangang Liu; Qixuan Bai; Jitao Song; Jia Guan; Jie Gao; Bingrong Liu; Xiao Ma; Yaju Du
Journal:  Mol Med Rep       Date:  2011-06-02       Impact factor: 2.952

Review 3.  Obesity, inflammation, and liver cancer.

Authors:  Beicheng Sun; Michael Karin
Journal:  J Hepatol       Date:  2011-11-25       Impact factor: 25.083

4.  Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.

Authors:  Katsumi Iizuka; Bonnie Miller; Kosaku Uyeda
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-05-16       Impact factor: 4.310

5.  Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease.

Authors:  Masaru Sakurai; Toshinari Takamura; Tsuguhito Ota; Hitoshi Ando; Hiroshi Akahori; Kyosuke Kaji; Motoko Sasaki; Yasuni Nakanuma; Katsuyuki Miura; Shuichi Kaneko
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

Review 6.  The role of the lipogenic pathway in the development of hepatic steatosis.

Authors:  C Postic; J Girard
Journal:  Diabetes Metab       Date:  2008-12       Impact factor: 6.041

7.  Evaluation and pharmacovigilance of projects promoting cultivation and local use of Artemisia annua for malaria.

Authors:  Merlin L Willcox; Shelly Burton; Rosalia Oyweka; Rehema Namyalo; Simon Challand; Keith Lindsey
Journal:  Malar J       Date:  2011-04-11       Impact factor: 2.979

8.  α-glucosidase inhibitors from plants: A natural approach to treat diabetes.

Authors:  Sunil Kumar; Smita Narwal; Vipin Kumar; Om Prakash
Journal:  Pharmacogn Rev       Date:  2011-01

9.  Myricetin Increases Hepatic Peroxisome Proliferator-Activated Receptor α Protein Expression and Decreases Plasma Lipids and Adiposity in Rats.

Authors:  Chia Ju Chang; Thing-Fong Tzeng; Shorong-Shii Liou; Yuan-Shiun Chang; I-Min Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-08       Impact factor: 2.629

10.  Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet.

Authors:  Ha-Neul Choi; Min-Jung Kang; Soo-Jin Lee; Jung-In Kim
Journal:  Nutr Res Pract       Date:  2014-06-30       Impact factor: 1.926

View more
  14 in total

Review 1.  Herbal medicines and nonalcoholic fatty liver disease.

Authors:  Hong Yao; Yu-Jie Qiao; Ya-Li Zhao; Xu-Feng Tao; Li-Na Xu; Lian-Hong Yin; Yan Qi; Jin-Yong Peng
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

2.  Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.

Authors:  Changlei Bao; Qian He; Hui Wang; Yanan Sun; Yahang Xu; Yan Pan; Yadan Hu; Shichuang Zheng; Shuxin Liang; Ang Luo; Tanzilan Nahar; Jiwang Chen; Haiyang Tang; Ying Han
Journal:  Oxid Med Cell Longev       Date:  2022-06-17       Impact factor: 7.310

3.  Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts.

Authors:  Sun Kyoung Lee; Hyungkeun Kim; Junhee Park; Hyun-Jeong Kim; Ki Rim Kim; Seung Hwa Son; Kwang-Kyun Park; Won-Yoon Chung
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

4.  Anti-Obesity Effects of Artemisia annua Extract in Zucker Fatty Rats and High-Fat Diet Sprague Dawley Rats through Upregulation of Uncoupling Protein 1.

Authors:  Eun-Yong Choi; Chan Young Park; Seong Hyun Ho; Su-Jin Park; Donghyun Kim; Byoungduck Han; Seon-Hee Kim
Journal:  J Obes Metab Syndr       Date:  2021-03-30

5.  Artemisinin Improves Acetylcholine-Induced Vasodilatation in Rats with Primary Hypertension.

Authors:  Xuanxuan Liu; Xingxing Wang; Yan Pan; Li Zhao; Shuo Sun; Ang Luo; Changlei Bao; Haiyang Tang; Ying Han
Journal:  Drug Des Devel Ther       Date:  2021-11-02       Impact factor: 4.162

Review 6.  A Systematic Review of Anti-malarial Properties, Immunosuppressive Properties, Anti-inflammatory Properties, and Anti-cancer Properties of Artemisia Annua.

Authors:  Samira Alesaeidi; Sepide Miraj
Journal:  Electron Physician       Date:  2016-10-25

7.  Antidiabetic and Antiobesity Effects of Artemether in db/db Mice.

Authors:  Yu Guo; Wei Fu; Yakai Xin; Jinlei Bai; Huifang Peng; Liujun Fu; Jie Liu; Liping Li; Yujin Ma; Hongwei Jiang
Journal:  Biomed Res Int       Date:  2018-05-13       Impact factor: 3.411

Review 8.  Chinese Medicine in the Battle Against Obesity and Metabolic Diseases.

Authors:  Lingyan Xu; Wenjun Zhao; Dongmei Wang; Xinran Ma
Journal:  Front Physiol       Date:  2018-07-06       Impact factor: 4.566

9.  Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice.

Authors:  Wei Fu; Yujin Ma; Liping Li; Jie Liu; Liujun Fu; Yu Guo; Zhiyin Zhang; Jiaxi Li; Hongwei Jiang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-19       Impact factor: 3.168

10.  Antidiabetic Effect of Artemether in Db/Db Mice Involves Regulation of AMPK and PI3K/Akt Pathways.

Authors:  Xiaolin Bai; Ruixia Pei; Wen Lei; Meiyun Zhao; Jialin Zhang; Lu Tian; Junke Shang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.